ESR1 and bone metastasis: CTC≥5/7.5mL (4.8× increased risk of bone metastasis),ctDNA ESR1 mutations (3–6 months early warning of resistance),134 gene CTC signature (distinguishes bone only vs. extra skeletal metastases)